Firm Named as Finalist for its Involvement as the Exclusive Financial Advisor in the Privatization of Several Louisiana State University (LSU) Hospitals
The M&A Advisor is pleased to announce finalists of the 13th Annual M&A Advisor Awards. SC&H Capital, an investment banking and advisory firm focused on middle market and growth companies, was named a finalist in the Deal of the Year and Healthcare/Life Sciences Deal of the Year categories for its involvement as the exclusive financial advisor in the privatization of several Louisiana State University (LSU) hospitals.
SC&H Capital supported LSU Health Sciences Center at Shreveport (LSUHSC-S) in its public/private partnership with the Biomedical Research Foundation of Northwest Louisiana (BRF), with respect to two acute care facilities currently operated by LSUHSC-S.
In addition to these deals, SC&H Capital served as the exclusive financial advisor for Huey P. Long Medical Center in Alexandria, Louisiana, in its public private partnership with two parties: CHRISTUS Healthcare and Rapides Healthcare, a subsidiary of HCA Holdings, Inc.
The winners for M&A Deal of the Year, Restructuring Deal of the Year, Cross-Border Deal of the Year, Corporate/Strategic Acquisition of the Year, Deal Financing of the Year, Sector Deals of the Year, Firms of the Year, M&A Product/Service of the Year and M&A Professionals categories will be announced at the 13th Annual M&A Advisor Awards Gala on Monday, November 17th at the New York Athletic Club.
“Since the inception of the M&A Advisor Awards in 2002, we have been recognizing the leading dealmakers, firms and transactions. And each year we celebrate the creativity, perseverance and ingenuity of our industry’s professionals,” says David Fergusson, President of The M&A Advisor. “While our industry has undergone significant transformation since our first awards were presented 12 years ago, we are convinced, more than ever before, that M&A is a driving force of the economy. It is truly an honor for our firm to be able to recognize the contribution that the 2014 award finalists have made.”
“SC&H Capital is known for facilitating transactions that are the best cultural, personal, and financial fit for our clients, which has enabled significant growth in areas such as healthcare,” said Christopher Helmrath, Managing Director, SC&H Capital. “These were particularly complex deals that were very political in nature, even within the healthcare arena. They both involved many third-parties and government agencies, and required key in-depth financial insights that the SC&H Capital team provided throughout the entire process.”
“SC&H Capital, representing the best of the industry, has demonstrated creativity and perseverance in today’s challenging climate,” says Roger Aguinaldo, CEO and Founder of The M&A Advisor.
For a detailed list of all of the Award Finalists for the 13th Annual M&A Advisor Awards, please CLICK HERE.
About SC&H Capital
SC&H Capital, an affiliate of SC&H Group, LLC, is an investment banking and advisory firm focused on middle market and growth companies. SC&H Capital supports their investment banking activity with a full suite of strategic and financial resources to assist companies in the development and execution of strategic plans and initiatives. In conjunction with SC&H Group, LLC, SC&H Capital tailors their advisory services to ensure that their clients receive pertinent and valuable advice in every stage of the business life cycle – not just at the time of sale. To learn more visit https://www.schgroup.com/services/investment-banking-advisory.
Securities offered through SC&H Capital Corporation, member FINRA/SIPC.
About The M&A Advisor
The M&A Advisor was founded in 1998 to offer insights and intelligence on M&A activities. Over the past sixteen years, through our research, reporting, publishing, symposiums and awards we have established the world’s premier network of mergers and acquisitions, restructuring and financing professionals. To learn more visit http://www.maadvisor.com.
